Famous investment firm Paulson & Co has acquired an undisclosed stake in Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) as the drug maker recovers from inventory pileup issues and the exit of its chief financial officer.
Paulson & Co’s acquisition in Salix headlines its health-care holdings, as it is also the third-biggest shareholder of Shire Plc.
Paulson’s stake in Salix
Citing people familiar with the developments, Olivia Oran, Nadia Damouni and Jessica Toonkel of Reuters report that the hedge fund firm Paulson & Co has taken a stake in the Setup a free account to get access to this article (no credit card required).Login required to continue reading.
Already a member? Log in here
